The effect of eucalyptus extract aroma on anxiety and sleep disorders in hemodialysis patients.

The effect of eucalyptus oil aromatherapy on anxiety and sleep disorders of hemodialysis patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20260422069132N1

Enrollment

Registered

2026-05-10

Start date

2026-06-05

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety and Sleep Disorders in Hemodialysis Patients.

Interventions

Intervention 1: Intervention group:The intervention group will receive aromatherapy during each dialysis session for 6 weeks (18-24 sessions, depending on the number of dialysis sessions per week (twi

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Willingness to participate in the project Having anxiety disorders The person does not have any mental or underlying disorders Obtaining a score of 20 as the cut-off point of the Spielberger Anxiety Questionnaire and also obtaining a score of 5 or higher as the cut-off point of the Pittsburgh Sleep Quality Questionnaire They had no smell problems They were not taking any medication for anxiety or sleep disorders The patients were undergoing hemodialysis (HD) treatment for at least 6 months, the patients underwent hemodialysis treatment (at least) three times a week, each time for three to five hours

Exclusion criteria

Exclusion criteria: Failure to comply with and complete training Withdrawing from further participation in the study The patient is allergic to medication or has a sense of smell disorder.

Design outcomes

Primary

Measure	Time frame
Outcome Variable 1:The level of anxiety in patients undergoing hemodialysis, measured using the Spielberger State–Trait Anxiety Inventory (STAI). This variable will be assessed at two time points: before the start of the intervention and at the end of the sixth week after the implementation of aromatherapy with eucalyptus essential oil. Outcome Variable 2:Sleep quality in patients undergoing hemodialysis, measured using the Pittsburgh Sleep Quality Index (PSQI). This variable will also be assessed at two time points: before the start of the intervention and at the end of the sixth week after the implementation of aromatherapy with eucalyptus essential oil. Timepoint: After 6 weeks of hemodialysis. Method of measurement: Spielberger Anxiety Questionnaire and Pittsburgh Sleep Disorders Questionnaire.	—

Measure

Time frame

Outcome Variable 1:The level of anxiety in patients undergoing hemodialysis, measured using the Spielberger State–Trait Anxiety Inventory (STAI). This variable will be assessed at two time points: before the start of the intervention and at the end of the sixth week after the implementation of aromatherapy with eucalyptus essential oil. Outcome Variable 2:Sleep quality in patients undergoing hemodialysis, measured using the Pittsburgh Sleep Quality Index (PSQI). This variable will also be assessed at two time points: before the start of the intervention and at the end of the sixth week after the implementation of aromatherapy with eucalyptus essential oil. Timepoint: After 6 weeks of hemodialysis. Method of measurement: Spielberger Anxiety Questionnaire and Pittsburgh Sleep Disorders Questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNeda Pishbin nooghabi

Gonabad University of Medical Sciences

nedapishbin@gmail.com+98 51 5723 1122

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026